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Natural or fertility awareness-based methods (FABMs) help users monitor, interpret, and 
systematically chart female biological markers.  FABMs are used as family planning methods 
and sometimes as reproductive health monitoring methods. The American College of 
Obstetricians and Gynecologists (ACOG) encourages medical professionals to use female 
reproductive cycle patterns, ‘the female fifth-vital sign’, as a means of improving the diagnosis 
and treatment of reproductive health diseases, disorders, and conditions.  Patients need to have 
accurate knowledge of healthy and unhealthy cycle patterns.  The general public does not have a 
sufficient level of fertility health knowledge.  This study examined whether females that are 
interested and not interested in using FABMs for health monitoring and family planning differ in 
their mean reproductive health knowledge scores (average of six knowledge questions), and 
whether certain demographic characteristics or having been prescribed the hormonal birth 
control pill for reproductive health abnormalities predict female interest in using FABMs for 
health monitoring or family planning.  A 52-item survey was administered to a national sample 
of 665 reproductive age women in March 2018.  An independent samples t-test and two binary 
regression models were run using the Statistical Package for Social Sciences software (SPSS).  
Of the total 665 female participants 279 (41.9%) females reported not being interested in using 
FABMs for family planning and 386 (58%) females are interested.  Females who were not 
interested in using FABMs for health monitoring (n=352) had a statistically significantly (p<.05) 
higher mean knowledge scores (73.6%) compared with the knowledge scores (68.8%) of females 
who were interested (n=237).  Similarly, females who were not interested in using FABMs for 
family planning (n=279) had a statistically significantly (p<.05) higher mean knowledge scores 
(75.1%) compared with the knowledge scores (69%) of females (n= 386) who were interested.  
No demographic characteristics nor having been prescribed the hormonal birth control pill for 
reproductive health abnormalities significantly predicted female interest in using FABMs for 
health monitoring or family planning.  These findings suggest that interest in FABMs for family 
planning or health monitoring is not isolated to a specific demographic of reproductive age 
women.  
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Evidence suggests that one in 10 women worldwide are affected by endometriosis which 
can lead to infertility (Research priorities in endometriosis published, 2009).  In fact, data from 
the 2002 National Survey of Family Growth (NSFG) conducted by the Centers for Disease 
Control and Prevention (CDC) estimated 7.3 million American women aged 15–44 years had 
impaired fecundity (i.e., experienced difficulties conceiving or bringing a pregnancy to term 
during their lifetime), with 11.5% of them receiving infertility services (Chandra, Martinez, 
Mosher, Abma, & Jones, 2005). In addition, some women of reproductive age suffer from a 
variety of chronic and acute reproductive health problems, including: infertility, endometriosis, 
polycystic ovarian disease, premenstrual syndrome, uterine fibroids, heavy or painful periods, 
and hypothalamic amenorrhea (Boyle, de Groot, Andralojc, & Parnell, 2018; Common 
Reproductive Health Concerns for Women, 2018; Nnoaham et al., 2011; Vigil, Ceric, Cortés, & 
Klaus, 2006).   
The United States’ public health initiative, Healthy People 2020, identified the reception 
of reproductive health services as a leading health indicator for reproductive and sexual health 
attainment (U.S. Department of Health and Human Services (USDHHS), 2010). The American 
College of Obstetricians and Gynecologists (ACOG) encourages patients, as early as 
adolescents, and primary care clinicians to discuss reproductive health patterns at every patient 
visit in an effort to improve the diagnosis and treatment of reproductive health problems 
(American College of Obstetricians and Gynecologists, 2015).  However, research suggests that 
40% of American women do not know about or understand their fertility cycles, and are 
therefore ill-equipped to monitor their reproductive health patterns (ACOG, 2015; Lundsberg, 
Pal, Gariepy, Xu, Chu, & Illuzzi, 2014).  In addition, clinicians continue to prescribe the 
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hormonal birth control pill as the first-line of treatment for symptoms related to a variety of 
reproductive health problems (Legro et al., 2013).  Prescribing hormonal birth control contradicts 
ACOG's recommendation to have females monitor their cycle patterns and receive treatments 
that correct underlying reproductive health problems, not simply manage symptoms (ACOG, 
2015).  
On the other hand, natural or fertility awareness-based methods (FABMs) are 
comprehensive reproductive health methods that enable women to monitor, manage, and 
maintain their reproductive health as well as plan their family (Boyle et al., 2018; Hilgers, 2004; 
Institute for Reproductive Health, n.d.; Smoley, & Robinson, 2012; World Health Organization, 
1995).  FABMs are evidence based methods that have no side effects, and are free of hormonal 
therapies, injections, and implants (Manhart, Duane, Lind, Sinai, & Golden-Tevald, 2013; 
Urrutia et al., 2018).  Certain FABM educational programs provide direct instruction to users 
providing them with necessary knowledge about biological markers, as well as have the skills to 
follow evidence based protocols for tracking and charting reproductive health patterns (Arevalo, 
Jennings, Nikula, & Sinai, 2004; Arevalo, Jennings, & Sinai, 2002; Bhargava, Bhatia, 
Ramachandran, Rohatgi, & Sinha, 1996; Fehring, Schneider, Raviele, Rodriguez, & Pruszynski, 
2013; Frank-Herrmann et al., 2007; Howard, & Stanford, 1999; Peterson et al., 2000).  Research 
suggests that charting with a FABM produces an effective diagnostic tool for identifying and 
treating underlying causes of reproductive health problems, including infertility (Boyle et al., 
2018; Hilgers, 2004; Vigil et al., 2006).  In addition, FABMs are effective and comprehensive 
family planning methods, helping couples to avoid and achieve pregnancy (Boyle et al., 2018; 
Manhart et al., 2013; Urrutia et al., 2018).  Therefore, women can potentially use FABMs to 
access the full scope of reproductive health services: family planning, health monitoring, and 
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knowledge about healthy menstrual cycle patterns (Boyle et al., 2018; Hilgers, T.W. 2004; Vigil 
et al., 2006).  However, we do not yet know if females are interested in using FABMs for health 
monitoring or if females are still interested in using them for family planning. 
Family Planning 
Beginning at the onset of puberty, healthy males are always fertile, constantly producing 
sperm (Hilgers, 2002).  Females are mostly infertile during their reproductive years (Duane, 
2019; Hilgers, 2002).  A female’s reproductive years range from 12 to 51 years of age (ACOG, 
2015).  Over the course of the average 21-35 day cycle a female ovulates once, typically 
releasing one egg, with an average fertile window of 6 days (Briden, 2017; Wilcox, Weinberg & 
Baird, 1995).  Given the physiological nature of the male and female reproductive systems an 
inclusive discussion of family planning must address the full scope of a couples’ reproductive 
capacity to either avoid or achieve pregnancy.    
Avoiding Pregnancy 
There are 6.1 million pregnancies each year in the United States; 45% of those are 
unplanned (Finer & Zolna, 2016).  Unplanned pregnancy rates are higher for Black and Hispanic 
women, 18-24 years old, partners that cohabit, those with an income below the poverty line, and 
those who have not completed high school (Finer & Zolna, 2016).  An inability to access family 
planning services also contributes to unplanned pregnancy rates (Chandra et al., 2005; Chandra-
Mouli, McCarraher, Philips, Williamson, & Hainsworth, 2014).  Barriers to access include cost, 
service office hours and locations, and a lack of knowledge of available resources and services in 
communities (Guttmacher Institute, 2014b).  Unplanned pregnancy is associated with negative 
maternal and infant health outcomes and an increase in cost to the general public (Child Trends, 
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2007; D’Angelo, Gilbert, Rochat, Santelli, & Herold, 2004; Guttmacher Institute, 2015; Tsui, 
McDonald-Mosley, & Burke, 2010).   
Healthy men and women have about a 30% chance of achieving a pregnancy resulting 
from random acts of sexual intercourse during a single female reproductive cycle, with an 82% 
chance of conception over the course of 12-months (Wilcox et al., 1995; Zinaman, Clegg, 
Brown, O’Connor, & Selevan, 1996).  The most effective method to avoid unplanned pregnancy 
is to abstain from all acts of sexual intercourse (American Academy of Pediatrics, 2016; “How 
effective are abstinence and outercourse?” 2019; “Sexual Risk Behaviors,” 2018).  1.5% of 
sexually active men and women practice periodic abstinence to avoid pregnancy (NCHS 
National Survey of Family Growth, 2018).  Most sexually active men and women use 
pharmaceutical birth control, sterilization procedures, or barrier methods to avoid pregnancy 
(NCHS National Survey of Family Growth, 2018).  Pharmaceutical birth control or barrier 
methods mitigate the chances of an unplanned pregnancy while remaining sexually active 
(Reproductive Health: Contraception, 2018).  Nearly all sexually active females report using a 
pharmaceutical birth control or barrier method during their lifetime (Daniels, Mosher & Jones, 
2013).  In the United States the most common methods of birth control are female sterilization 
(18.6%), the oral birth control pill (12.6%), long-acting reversible contraceptives (LARCs) 
(10.3%), and male condoms (8.7%).  Typical use method effectiveness rates for avoiding 
pregnancy range from 99% (hormonal implant-LARC) to 87% (male condom) (Reproductive 
Health: Contraception, 2018).  Despite high effectiveness rates, 47% of women who have used at 
least one method of birth control will discontinue use due to dissatisfaction with the method 
(Daniels et al., 2013).  The most commonly cited reason for discontinuation of hormonal 




effects (Daniels et al., 2013).  Therefore, females that are able to access family planning services 
may not find a method with which they are satisfied.  In addition, a variety of factors influence a 
woman’s choice of birth control including: birth control options available, cost of method, sexual 
partnership characteristics, how frequently they engage in sexual intercourse, religious 
affiliation, pregnancy and method related experiences (having had an unplanned pregnancy while 
using a birth control pill in the past), and attitudes toward use of the method  (Daniels et al., 
2013; Guttmacher Institute, 2014a; Wiesman, Lehman, Legro, Velott, & Chuang, 2015).  
Therefore, helping women and couples find, access, and effectively use methods to avoid 
pregnancy that are free of side-effects, are cost effective, and address other influencing factors 
will help couples achieve planned pregnancies and avoid unplanned pregnancy.  Eventually 
leading to improved health, social, and economic outcomes for parents and children (Cheng, 
Schwarz, Douglas, & Horon, 2008; Child Trends, 2007; D’Angelo, Gilbert, Rochat, Santelli, & 
Herold, 2004; Finer, & Zolna, 2016; Guttmacher Institute, 2015; Kost, Landry, & Darroch, 1998; 
Tsui et al., 2010). 
Achieving Pregnancy 
Conception requires the presence of healthy male sperm, a healthy female egg, and the 
presence of high quality female cervical fluid (Hilgers, 2002; Odeblad, 1994).  When a healthy 
man and woman engage in random acts of sexual intercourse they have a 30 percent chance of 
conceiving a child during each reproductive cycle (Wilcox et al., 1995; Zinaman et al., 1996).  
The majority of men and women report that parenthood is a goal for their future (Hammarberg et 
al., 2017a; Prior, Lew, Hammarberg, & Johnson, 2018; Sorensen et al., 2016).  On average men 
and women desire or expect to have two or more children during their reproductive life (National 




decreased likelihood of a couple achieving a pregnancy include: age, weight (overweight or 
underweight), diet, alcohol consumption, stress, level of caffeine intake, smoking, presence of 
reproductive disease, and sexual health history (Centers for Disease Control and Prevention, 
2014).  Research suggests the general public is not knowledgeable about these factors and 
research suggests that more people are starting families later in life (Bunting et al., 2013; 
Hammarberg, Collins, Holden, Young, & McLachlan, 2017a; Hammarberg et al., 2017b; 
Houston, Abraham, Huang, & D'Angelo, 2006; Lundsberg et al., 2014; Peterson et al., 2012).  
Additionally, male and female fertility experiences in the United States differ when considering 
factors such as: level of educational level, household income in relation to the federal poverty 
line, and Hispanic origin and race (National Center for Health Statistics, 2018b).   
Reproductive Health 
 Reproductive health refers to the diseases, disorders, and conditions that affect the 
functioning of the male or female reproductive system at every stage of life (Reproductive 
Health, 2018).  Examples of female reproductive diseases are endometriosis, polycystic ovarian 
disease (PCOS), uterine fibroids, gynecologic cancers (cervical, uterine, ovarian), sexually 
transmitted infections (STI), premenstrual syndrome (PMS), and ovarian dysfunction (Common 
Reproductive Health Concerns for Women, 2018; Houston, Abraham, Huang, & D’Angelo, 
2006; Vigil et al., 2006).  Reproductive diseases, disorders, and conditions can result in impaired 
fecundity, the inability to conceive or carry a pregnancy to term and have a live birth (Common 
Reproductive Health Concerns for Women, 2018).  At least 6% women are unable to achieve a 
pregnancy after engaging in sexual intercourse for 12 months (Boyle et al., 2018).  While almost 
15% of women will experience a miscarriage during the first trimester of pregnancy (Cohain, 




The average female enters menarche, onset of menstruation, around the age of 12 or 13 
(ACOG, 2015).  However, a female begins the process of reproductive maturation as an embryo 
(Vigil, Lyon, Flores, Rioseco, & Serrano, 2017).  Female reproductive functioning begins in the 
brain with communication between the hypothalamus and pituitary gland, the HPO axis (Popat, 
Prodanov, Calis, & Nelson, 2009).  Evidence suggests that it takes years for the HPO axis to 
mature (Mansfield & Emans, 1989).  Establishing a healthy HPO axis and regular cycle patterns 
is associated with an adolescent’s body weight, diet, gene structure, the presence of synthetic or 
artificial hormones, as well as environmental factors (Briden, 2017; Damstra, 2002; Mansfield & 
Emans, 1989; Popat et al., 2009; Vandenberg et al., 2012; Vigil et al., 2017; World Health 
Organization, 2011).  During this time, it is normal for adolescent females to experience irregular 
cycle patterns (Mansfield & Emans, 1989).  When cycle irregularity is not attributed to a 
maturing HPO axis, but an other anatomic or endocrine problem, underlying reproductive 
diseases, disorders, and conditions should be medically investigated (Mansfield & Emans, 1984; 
Popat et al., 2009; Vigil et al., 2017).   
As much as 75% of adolescent females, ages 10-19 years old, report problems with 
menstruation as their primary reason for doctor’s visits (Slap, 2003).  In December 2015, ACOG, 
endorsed by The American Academy of Pediatrics, published a committee opinion encouraging 
physicians to inquire about their adolescent patients’ menstrual pattern at every appointment 
(ACOG, 2015).  Tracking cycle patterns during adolescence, dubbed tracking the female ‘fifth 
vital sign’, can help clinicians identify and treat a variety of female reproductive problems 
(ACOG, 2015).  This suggestion is negated when physicians use the hormonal birth control pill 
as the first-line of treatment for reproductive problems (Legro et al., 2013).  In fact, one in three 




Lambert, 2015).   However, when females track their natural menstrual cycle patterns using 
cooperative and corrective treatments underlying causes of symptoms can be addressed (ACOG, 
2015; Brown, 2011; Mansfield & Emans, 1984; Popat et al., 2008; Vigil et al., 2006).  Early 
diagnosis and treatment of various reproductive problems may prevent infertility and impaired 
fecundity in the later stages of a woman's reproductive years (Centers for Disease Control and 
Prevention, 2014).  Currently, an accurate diagnosis of certain reproductive disorders can take up 
to 11 years, and can be associated with an inept production of natural female hormones (Briden, 
2017; Ding et al., 2017; Goodman et al., 2015; Rogers et al., 2009; Sinaii, Cleary, Ballweg, 
Nieman, & Stratton, 2002).  Research suggests there are many short and long-term health 
benefits associated with the natural production and fluctuation of ovarian hormones, estradiol 
and progesterone (Briden, 2017; Manuvais-Jarvis, Clegg, & Hevener, 2013; Mecangi et al., 
2014; Mohammed et al., 2015; ; Mong et al., 2011; Prior, 2014; Sathi, Kalyan, Hitchcock, 
Pudek, & Prior, 2013; Schussler et al., 2008; Smith et al., 2014).  Therefore, earlier diagnosis and 
treatment of reproductive diseases may allow females to experience the health benefits 
associated with natural progesterone and estrogen (Briden, 2017; Manuvais-Jarvis et al., 2013; 
Mecangi et al., 2014; Mohammed et al., 2015; ; Mong et al., 2011; Prior, 2014; Sathi et al., 2013; 





Female Reproductive Health Knowledge 
Reproductive cycle phases are distinct from one another, yet work systematically to 
orchestrate a functioning reproductive cycle (Briden, 2017; Hilgers, 2002; Vigil et al., 2017).  
The fluctuation of hormones, beginning in the female brain and endocrine system, is essential for 
the overall health and function of the reproductive cycle (Popat et al., 2009).  The follicular 
phase begins with the first day of menstruation and continues until ovulation (Briden, 2017; 
Fehring, Schneider, & Raviele, 2006).  Ovulation happens once each cycle; however, the process 
of follicular maturation leading to ovulation takes 100 days (Briden, 2017).  A healthy ovulatory 
event precedes a healthy luteal phase, 9-17 days in length, and a healthy menses (Briden, 2017; 
Fehring, Schneider & Raviele, 2006; Hilgers, 2002).  Sufficient knowledge about each phase of 
the cycle, not just ovulation or menstruation, constitutes adequate reproductive health 
knowledge.  The ability to identify healthy and unhealthy cycle patterns is an important skill for 
females seeking care for reproductive cycle problems (ACOG, 2015) 
Findings from previous research suggests the general public, practicing medical 
professionals, and medical trainees, are lacking knowledge of fertility health topics in different 
ways (Kudesia, Chernyak, & McAvey, 2017; Lampic, Svanberg, Karlstrom, & Tyden, 2006; 
Lundsberg et al., 2014; Peterson et al., 2012; Prior et al., 2018; Slap, 2003; Sørensen et al., 2016; 
Stern, Larsson, Kristiansson, & Tyden, 2013).  These studies primarily explored the amount of 
knowledge participants had about ovulation, family planning intentions, assisted reproductive 
technologies, physiological and life-style factors impacting the ability to achieve pregnancy, and 
menstruation (Kudesia et al., 2017; Lampic et al., 2006; Lundsberg et al., 2014; Peterson et al., 
2012; Prior et al., 2018; Slap, 2003; Sorensen et al., 2016; Stern et al., 2013).  While other 




menstruation they failed to investigate participants’ knowledge of healthy reproductive cycle 
patterns (e.g., “How long is a healthy menses?”, or “What is a healthy cycle length, in days?”)  
(Houston et al., 2006; Lundsberg et al., 2014; Slap, 2003).  Knowledge and understanding of 
healthy reproductive cycle patterns can help patients identify abnormalities and seek a diagnosis 
or receive treatment for a reproductive disease, disorder, or condition (ACOG, 2015; Boyle et al., 
2018; Hilgers, 2004; Popat et al., 2009; Vigil et al., 2006).   
Having knowledge about healthy reproductive cycle patterns is important for the general 
and medical populations (ACOG, 2015).  Research suggests that males and females want to 
know and understand their fertility health (Hampton, Mazza, & Newton, 2013; Lundsberg et al., 
2014).  However, one study found that 40% of women aged 18-40 were not knowledgeable 
about when ovulation occurs or the characteristics of cervical fluid secretions that are observable 
during that cycle phase (Lundsberg et al., 2014).  The same study also reported that 40% of 
women were unaware that females do not produce new eggs during their reproductive life 
(Lundsberg et al., 2014).  Although, Lundsberg et al., (2014) found that the majority of women 
(70%) believe that females should consider their reproductive health well before they are ready 
to conceive. 
Fertility Awareness Based Methods (FABMs) 
 
 Natural or fertility awareness-based methods (FABMs) refer to family planning methods 
that allow users to identify various external biological markers that are indicative of their fertility 
health (Odeblad, 1994; Pallone & Bergus, 2009; Pyper, 1997; Smoley & Robinson, 2012).  
External biological markers can include: basal body temperature, urinary metabolites, and 
cervical fluid secretions (Odeblad, 1994; Su et al., 2017).  All FABMs are free of artificial 




et al., 2018).  Additionally, some FABMs can help users achieve pregnancy and monitor their 
reproductive health (from menarche to menopause) (Boyle et al., 2018; Hilgers 2004; Vigil et al., 
2006).  Thus, FABMs can be used to meet a wide range of female reproductive health needs: 
family planning (achieving or avoiding) and monitoring reproductive health.  Despite the utility 
of modern FABMs, and the research suggesting women are interested in using FABMs for 
family planning, it is estimated that only 1% to 3% of reproductive age females in the United 
States are currently using a FABM (as cited in Pallone & Bergus, 2009; Stanford, Lemaire, & 
Thurman, 1998).  These estimates only reflect rates of FABM use for family planning.  There is 
no information about the percent of females that are using a FABM for health monitoring.  
FABMs are family planning options suggested for use by the World Health Organization 
(WHO), American College of Obstetricians and Gynecologists (ACOG), Centers for Disease 
Control and Prevention (CDC) and most recently by the Food and Drug Administration (FDA) 
(ACOG, 2019; “Contraception,” 2018; “FDA Allows Marketing of First,” 2018; World Health 
Organization, 1988).  
Five Primary Types 
 FABMs are often classified based on their underlying mechanism(s) of action (Smoley & 
Robinson, 2012).  The five primary FABM categories are calendar methods, lactation methods, 
cervical fluid methods, sympto-thermal methods, or sympto-hormonal methods (Fehring et al., 
2013; Smoley & Robinson, 2012).  Some FABMs can be used to help couples achieve 
pregnancy; however, they are commonly discussed as methods to avoid pregnancy (Boyle, 2017; 
Hilgers, 2004; Manhart et al., 2013; Urrutia et al, 2018).  Effectiveness rates for avoiding 





Calendar and Lactation Methods. 
 
The Standard Days Method® (SDM), is an effective, inexpensive and modern calendar-
based family planning method (Arevalo et al., 2002).  Developed by Georgetown University's 
Institute for Reproductive Health (IRH), SDM helps women avoid pregnancy by using a color-
coded string of beads, CycleBeads®, to track when they are menstruating and when they are most 
likely to be fertile (Sinai, Jennings & Arévalo, 2004).  Users do not monitor external biological 
markers.  This modern calendar based method is for women with regular length cycles, ranging 
from 26-32 days which encompasses 80% of female cycles (Arevalo et al., 2002; Sinai, Jennings 
& Arévalo, 2004).  With perfect use, 5% of women will get pregnant after one year (Arevalo et 
al., 2002).  With typical use, 12% of women will experience an unplanned pregnancy after one 
year (Arevalo et al., 2002).   
The Lactational Amenorrhea Method (LAM) is based on the scientific understanding of 
the natural suppressive effect that exclusive breastfeeding has on female ovulation for up to six 
months postpartum (Labbock et al., 1997).  During breastfeeding, the nipple stimulation that 
results from infant suckling interferes with hormone communication between the brain and ovary 
which suppresses ovulation (Chao, 1987).  The LAM protocol is highly effective at helping 
postpartum mothers avoid pregnancy if they have not had a return of menses, are exclusively and 
frequently breastfeeding (daytime and nighttime), and their infant is less than 6 months old 
(Labbock et al., 1997).  Postpartum mothers make no observations of biological markers when 
using LAM.  The perfect use rate for avoiding pregnant is 99% and the typical use rate is 98% 






Cervical Fluid Methods. 
Three FABM mucus methods will be discussed here, The Billings Ovulation Method 
(Billings Method), The Creighton Model FertilityCare System (Creighton Model), and the Two 
Day Method.  Cervical fluid method users identify their ovulatory phase by making external 
observations of fluid secretions present at the vulva (Fehring, 2002; Odeblad, 1994).  Daily 
tracking of cervical fluid informs users about their reproductive cycle phase (fertile or infertile) 
and health (Fehring, 2002; Hilgers, 2004; Odeblad, 1994; Vigil et al., 2017).  Protocols have 
been developed for Billings and Creighton Model users with various cycle patterns (irregular, 
regular, anovulatory, post-partum, etc…).  Perfect use pregnancy rates among the 
aforementioned methods range from 0.1 to 3.5 per 100 women years (Hilgers & Stanford, 1998; 
Urrutia et al., 2018).  Use effective pregnancy rates range from 3.2 to 33.6 per 100 women years 
(Hilgers & Stanford, 1998; Urrutia et al., 2018). 
 Sympto-Thermal and Sympto-Hormonal Methods. 
 Once a female ovulates the rise in progesterone has a thermogenic effect on her basal 
body temperature raising it by 0.5-1.0-degree Fahrenheit for the duration of the luteal phase (Su 
et al., 2017).  Tracking basal body temperature is a retrospective indicator that ovulation has 
occurred.  Method users take their basal body temperature at the same time every day and track 
cervical fluid secretions, count calendar days, or feel for the positioning of the cervix (Smoley & 
Robinson, 2012; Urrutia et al., 2018).  Typical use pregnancy probability rates range from 1.8-33 
unplanned pregnancies per 100 women years, with perfect use pregnancy rates ranging from 0.4-
12 unplanned pregnancies per 100 women years (Urrutia et al., 2018).   
Approximately 35-44 hours prior to ovulation a female will experience a rise in her 




(Cahill, Wardle, Harlow, & Hull, 1998; Hoff, Quigley, & Yen, 1983; Su et al., 2017).  Users of a 
sympto-hormonal method track daily urinary LH levels using a digital hormone reader, or a 
digital reader and cervical fluid observations (Fehring, Schneider, Raviele, & Barron, 2007).  
Typical use pregnancy probability rates range from 2-25.6 unplanned pregnancies per 100 
women years, with perfect use pregnancy rates ranging from 0-12.1 unplanned pregnancies per 
100 women years (Urrutia, 2018).  Some researchers propose that the use of a sympto-hormonal 
method is not always the most efficacious application of the underlying physiological science 
(Qublan et al.,, 2006; Su et al., 2017).  
Family Planning 
 Females and their partners use FABMs to inform their choice of when they will engage in 
sexual intercourse based on their family planning goals (Manhart et al., 2013; Urrutia et al, 
2018).  Evidence suggests that typical use failure rates for avoiding pregnancy are comparable 
between some FABMs and pharmaceutical or barrier methods (“Contraception,” 2018).  Typical 
use pregnancy rates for methods such as the hormonal shot, oral birth control pill, the patch, 
male or female condoms, and spermicides range from 4% to 21% (“Contraception,” 2018).  
Typical use pregnancy rates per 100 woman years for FABMs range from 2-23% (Urrutia et al., 
2018).  FABMs can help users identify days when they are fertile in order to target sexual 
intercourse when they want to achieve a pregnancy (Wilcox et al., 1995).  A couple’s time to 
pregnancy (TTP) is the number of female reproductive cycles that pass where acts of sexual 
intercourse take place and pregnancy is not achieved.  TTP can be lessened when sexual 
intercourse occurs on days associated with a high probability of conception taking place 






Based on recent evidence found from a systematic review of the literature, perfect use 
pregnancy probability rates for FABMs range from 0-12.1, and typical use pregnancy rates range 
from 0.4 to 33.6 per 100 woman-years (Urrutia et al., 2018).  Efficacious use of FABMs to avoid 
pregnancy stipulates that users abstain from sexual intercourse during the fertile window 
(Howard & Stanford, 1999; Manhart et al., 2013).  Furthermore, users experience greater degrees 
of effectiveness when avoiding pregnancy when they learn method protocols from trained 
educators (Arevalo et al., 2004; Arevalo et al., 2002; Bhargava et al., 1996; Hilgers & Stanford, 
1998; Howard, & Stanford, 1999; Fehring et al., 2013; Frank-Herrmann et al., 2007; Peterson et 
al., 2000; Sinai, Jennings & Arévalo, 2004).  The range of reported typical use and perfect use 
effectiveness rates reflects 1) different study designs 2) participant demographic characteristics 
3) the study’s timeline or approach used for determining participant’s pregnancy intentionality 4) 
study participants documented the use of barrier methods during the fertile window and 5) the 
mechanism(s) of action on which the method is based (Manhart et al., 2013; Urrutia et al., 2018).  
Further discussion of these topics is not pertinent to the focus of this paper; however, these issues 
are addressed in greater detail by scholars in published literature (Frank-Herrmann et al., 2007; 
Stanford & Dunson, 2007). While FABMs are commonly referenced as methods used to avoid 
pregnancy, some FABMs have evidence supporting their utility in helping reproductively healthy 
and unhealthy partners achieve pregnancy (Boyle et al., 2018; Gnoth, Godehardt, Godehardt, 
Frank-Herrmann, & Freundl, 2003; Stanford, & Dunson, 2007; Tham, Schliep, & Stanford, 






According to Wilcox, Weinberg, and Baird (1995), the majority of pregnancies are 
achieved when sexual intercourse takes place within a six-day window, ending with the day of 
ovulation.  In fact, evidence suggests that the optimal time for a couple to engage in sexual 
intercourse and have the highest likelihood of a single act resulting in a pregnancy is two days 
prior to ovulation (Tiplady, Jones, Campbell, Johnson, & Ledger, 2013).  Accurate identification 
and interpretation of cervical fluid secretions is an effective approach for females seeking to 
identify their six-day window of fertility (Odeblad, 1997).  However, research suggests the 
general public does not have this basic fertility knowledge (Kudesia et al., 2017; Lundsberg et 
al., 2014).  Most evidence based FABMs require that females and their partners receive direct 
and explicit instruction about biological markers, observational routines, and method specific 
tracking protocols from a trained FABM educator in order to effectively learn method protocols 
(Arevalo et al., 2004; Bhargava et al., 1996; Fehring et al., 2013; Hilgers & Stanford, 1998; 
Labbok et al., 1997; Sinai et al., 2004).  These educational phases address a variety of fertility 
knowledge topics (Arevalo et al., 2004; Bhargava et al., 1996; Fehring et al., 2013; Hilgers & 
Stanford, 1998; Labbok et al., 1997; Sinai et al., 2004).  Furthermore, the knowledge and 
understanding gained from working with FABM educators can equip method users with the 
necessary skills to track their cycle health, and to avoid or achieve pregnancy (Boyle et al., 2018; 





Female Reproductive Health 
FABMs can be used by females throughout their reproductive life (Arevalo et al., 2004; 
Arevalo et al., 2002; Bhargava et al., 1996; Briden, 2018; Chao, 1987; Fehring et al., 2007; 
Golden-Tevald, 2013; Hilgers, 2004; Tham et al., 2012; Vigil et al., 2006).  Cervical fluid 
methods work for females with varying cycle patterns: irregular, regular, anovulatory, 
premenopausal, postpartum, and breastfeeding (Bhargava et al., 1996; Chao, 1987; Fehring, 
Barron, & Schneider, 2005; Hilgers, 2004).  Evidence suggests that charting each phase of the 
female reproductive cycle using cervical fluid methods can address underlying reproductive 
diseases, disorders, and conditions (Boyle et al., 2018; Hilgers, 2004; Vigil et al., 2017; Vigil et 
al., 2006).  Charting is a diagnostic tool that allows trained clinicians to assess a patient’s 
reproductive health and use cooperative medical and surgical treatments to address and attempt 
to correct underlying causes of reproductive abnormalities (Tham et al., 2012; Stanford, Parnell, 
& Boyle et al., 2008; Vigil et al., 2017).  Furthermore, ACOG recommends females begin to 
track and chart their cycle patterns during adolescents (ACOG, 2015).  Charting during 
adolescence may help address the underlying causes of menstrual disorders that affect 75% of 
young female patients (ACOG, 2015; Slap, 2003).   
Restorative Reproductive Medicine (RRM) refers to reproductive medicine where by 
medical and surgical techniques are used to cooperatively restore reproductive health and ovarian 
function (Boyle et al., 2018).  Clinicians practicing RRM use patient charting as a diagnostic tool 
to assess and treat underlying causes of reproductive diseases that can lead to impaired fecundity 
(Boyle et al., 2018; Common Reproductive Health Concerns for Women, 2018; Hilgers, 2004; 
Stanford et al., 2008; Tham et al., 2012; Vigil et al., 2006).  Medical practices that establish 




hormones can lead to improved female health, pregnancy rates, and live birth outcomes (ACOG, 
2015; Boyle et al., 2017; Briden, 2017; Schüssler et al., 2008; HIlgers 2004; Popat et al., 2009; 
Prior, 2014; Vigil et al., 2017). 
In fact, one study examined where RRM treatments were used to correct underlying 
causes of impaired fecundity in couples who had not received IVF treatments and had struggled 
for an average of 5.6 years to have a child reported live birth rates of 61.5% (Stanford et al., 
2008).  More recent evidence suggests that for females of advanced maternal age (35-38 years 
old) and undergone multiple failed attempts of IVF treatment, they had a successful live birth 
rate of 37.5% with RRM (Boyle et al., 2018).  The same study reported that women over 40 who 
had undergone multiple failed attempts of IVF treatment, had a 27.4% live birth rate (Boyle et 
al., 2018). Compared with IVF, charting the female cycle with a FABM in conjunction with 
restorative reproductive healthcare results in more favorable outcomes for mothers and infants 
with potential economic savings to the health care system (Boyle et al., 2008; Centers for 
Disease Control and Prevention, 2018).   However, only 3-6% of medical professionals are 
knowledge about FABMs and there applications to women’s reproductive health (Stanford, 
Thurman & Lemaire, 1999).   
Current Study 
In 1998 and 2006 respectively, two separate cross-sectional survey studies reported 
female interest in using natural family planning (NFP) to avoid or achieve pregnancy in isolated 
populations in Missouri and Arizona (Leonard, Chavira, Coonrod, Hart, & Bay, 2006; Stanford 
et al., 1998).  These two studies suggested that a percentage of females are interested in using 
NFP methods for family planning (Leonard et al., 2006; Stanford et al., 1998).  In 1998, 22.5% 




37.4% were interested in using NFP to achieve a pregnancy (Stanford et al., 1998).  In 2006, 
61% of females said they would be ‘likely’ or ‘very likely’ to use a NFP method to avoid a 
pregnancy, and 50% said they would use NFP to try to achieve a pregnancy (Leonard et al., 
2006).  Leonard et al., (2006) and Stanford et al., (1998) used different survey instruments to 
measure females’ interest in FABMs in two different populations of females.   
These previously conducted surveys (1998 and 2006) are the most recent data available 
describing female’s interest in using NFP, and suffered from limitations. For example, the 1998 
study collected data from 484 potentially fertile women via mail-based surveys by randomly 
selected driver’s license renewal records in Missouri, between 1991 and 1992 (Stanford et al., 
1998). The 2006 study included 357 women, 82% of which were Hispanic, and collected survey 
responses from women of reproductive age (18 to 44) waiting for a medical appointment at one 
hospital system in Phoenix, AZ (Leonard et al., 2006).  Studies limited by geographic location 
and social indicators (e.g., having driver’s license) limit the conclusions that can be made 
(Leonard et al., 2006; Stanford et al., 1998).  In light of recent research suggesting the utility of 
FABMs in women’s healthcare it is appropriate to ask females if they are interested in using 
FABMs for family planning and health monitoring (Boyle et al., 2018; Hilgers, 2004; Vigil et al., 
2017).   
Using data collected from a national survey of reproductive age women, 18-55 years old 
in spring 2018, this study examined whether females were interested or not interested in using 
FABMS for family planning or health monitoring.  Previous studies found that pregnancy 
history, previous use of FABMs, future intention to have children and other factors predicted 
females interest in using FABMs for family planning (Leonard et al., 2006; Stanford et al., 




reproductive health abnormalities or certain demographic characteristics (age, race/ethnicity, 
marital/relationship status, religious affiliation, level of education, annual income, and health 
insurance status) or predicted females interest in using FABMs for health monitoring or family 
planning.  In contrast to previous research on FABM interest, this study also examined the 
difference in reproductive health knowledge between females that reported being interested and 
not interested in using FABMs for health monitoring and family planning.  Exploring knowledge 
score differences between interested and not interested females was predicted to be helpful the 
future planning of FABM public health programming.  Thus, female interest in FABMs was 
examined by asking two research questions, 1) Is there a difference in the mean reproductive 
health knowledge score between females that are interested in using FABMs for health 
monitoring and family planning and females that are not interested in using FABMs for health 
monitoring and family planning? and 2) Does having been prescribed the hormonal birth control 
pill for reproductive health abnormalities and certain demographic characteristics predict 
females’ interest in using FABMs for health monitoring or family planning?   
Methods 
Participants & Procedures 
 A national sample of 665 women of reproductive age, 18-55, completed an online survey 
between March 4, 2018 and March 11, 2018.  The survey was administered by Qualtrics Online 
Survey Company.  Qualtrics elicited incentivized participation from their national pool of 
participants who met specific eligibility criteria.  Eligibility criteria included being biologically 
female, between the ages of 18-55, be potentially fertile (i.e., having not had a hysterectomy, 
oophorectomy, or been sterilized, and having not yet entered menopause), and be currently or 




female partners.  Participants who indicated that they did not plan to ever engage in vaginal-
penile sexual intercourse or only engage in sexual intercourse with female partners were not 
prompted to complete the final section of the survey about family planning.  Participants read a 
consent clause prior to completing the survey that stated by beginning the survey they were 
consenting to participate.  All survey responses were anonymous and participation in the study 
was voluntary.  This study received approval from the Institutional Review Board (IRB) at the 
University of Arkansas prior to collecting data (see Appendix C). 
 In total, about 77% (n=512) of the participant were between the ages of 18 and 37 years 
old (M= 31, SD= 8.44) All participants identified as female (n=665).  Almost 73% (n=487) of the 
participants identified as being White/Caucasian.  Nearly 85% (n=561) of female participants 
were either living with a partner (n=119), married (n=262), or single (n=180).  Half of the 
participants, 51% (n=340), identified as Christian.  About 75% (n=503) of participants 
completed some college, have an associates, bachelors, masters, doctorate, medical doctor or 
other professional graduate degree. Exactly 17% (n=113) of participants reported an annual 
household income of less than $15,000 and 19% (n=129) of participants reported an annual 
household income of more than $75,000.  Lastly, 85% (n=557) of the participants responded, 
“Yes,” when asked whether or not they had health insurance (see Appendix A, Table 1 for more 





The survey consisted of 52 questions divided into three sections.  At the beginning of 
each section, participants were given a brief reading prompt explaining the aim of the survey 
section and included definitions of terminology found in the survey.  Each of the three sections 
within the survey included a participant screening question that read, “This question is to make 
sure you are truly reading and answering the questions. If you are reading and answering 
questions please choose, ‘I am reading and answering questions,’ as your answer choice.” The 
question format was close-ended, open-ended, and there was one matrix question.  Survey 
questions were created as well as adapted from previous studies and addressed: 1) personal 
knowledge about basic reproductive cycle health (e.g., length of days, knowledge of observable 
signs of fertility and infertility) 2) interest in use of FABMs for family planning (i.e., avoiding 
and achieving pregnancy when desired) 3) interest in use of FABMs to monitor health (for 
themselves and/or a family member – i.e. a daughter, niece, or young woman in their care) and 
4) prior family planning methods that had been used, duration of use, and reason(s) for 
use/discontinuation (Stanford et al., 1998; Leonard et al., 2006; see Appendix B for the complete 
survey).   
Demographics. Participants were asked to answer questions including their age, 
race/ethnicity, sexual identity, marital/relationship status, religious affiliation, educational 
attainment level, current household income, health insurance status, and reproductive health 
history.  Reproductive health history questions, “How many times have you been pregnant?”, 
“How many pregnancies have you had that resulted in the birth of a living child? (total number 
of children born alive)”, as well as a screening question asking participants to identify whether or 




history questions were taken from a previous survey evaluating female interest in FABMs for 
family planning (Stanford et al., 1998). 
Knowledge of female menstrual cycle.  Participants answered seven knowledge-based 
questions about the female menstrual cycle.  These questions were created based on previous 
research examining the general populations current fertility knowledge level as reported by 
Lundsberg et al., (2014), and in collaboration with professionals working in the field of 
reproductive healthcare. Various question formats were used. For example, some questions 
included “select all that apply” options (e.g., “What is considered a healthy menstrual cycle 
length?” ), multiple choice (e.g., “How many days in each menstrual cycle does a female 
ovulate?”, options included one, two, three, a woman can ovulate once a day for more than three 
days each cycle, and I don’t know), and True/False (e.g., “It is NOT necessary for a female to 
ovulate regularly (approximately once a month) in order to be considered healthy as long as she 
is regularly bleeding.”). True/False questions also included an “I don’t know” option.  
Participants were asked to identify where or from whom they learned information about healthy 
menstrual cycle patterns.  Knowledge question responses were scored as correct or incorrect. 
Previous reproductive health experiences.   Four survey questions inquired about 
female’s previous or current use of hormonal birth control to address an underlying reproductive 
health problem.  Question formats included, “yes or no” (e.g., “Have you ever used or are you 
currently using a birth control pill or other hormonal contraceptive method as a treatment for a 
reproductive health problem such as:   irregular cycles, painful periods, bad cramps, heavy 
periods, or other.”), and multiple choice,   (e.g., “If you have used, or are currently using, a birth 
control pill or other hormonal contraceptives as a treatment for a reproductive health problem, 




parent/family member, other).  The third question prompted participants with an answer choice 
option of “select all that apply” (e.g., “Select the reason you FIRST started using the birth 
control pill or other hormonal contraceptives to treat a reproductive health problem?”).  Lastly, 
females were asked to report at what age they recalled starting to use birth control to treat a 
health problem (e.g., “younger than 8 years old” to “after 50”). If participants responded, “no,” 
to ever having received hormonal birth control to treat a reproductive health condition they were 
automatically moved on to the next survey question.  
Willingness to perform health behaviors. Participants were asked about their willingness 
to perform health behaviors necessary to make observations of reproductive biological markers. 
This included seven statements explaining various health behavior practices required of FABM 
users. A Likert type scale was used to measure participant willingness to perform the stated 
health behavior.  An example statement is “Wiping with toilet tissue before and after EVERY 
bathroom visit looking for cervical fluid on a tissue.” Participants selected one answer choice 
(e.g., “I am NOT willing, I might be willing if I knew more, I am willing, I am already doing 
this”).  
Use of family planning methods. Participants were first asked to identify, “choose all that 
apply,” important characteristics they consider when choosing a family planning method (e.g., 
reliability, effectiveness, ease of use, acceptability of method to a partner, potential side effects, 
cost, or other).  Next, participants were asked to indicate which methods of family planning they 
were currently using or had previously used.  For prior use, participants were asked to report, via 
open ended textbox, the reason for discontinuation of the method. This section also asked three 
closed-ended and one open-ended question created by the researcher in collaboration with 




using them (e.g., “Do you use a period tracking OR fertility tracking app?”, “Which app or apps 
did you use?”, “What is your purpose(s) for using a period tracking or fertility tracking app?”, 
“What is your commitment to the period tracking or fertility tracking app?”) 
Familiarity with and interest in using FABMs.  Participants were asked a single multiple-
choice question to indicate when they would consider using FABMs (e.g., “When would you 
consider using a FABM?”).  Answer choices included, “For monitoring my health,” “For family 
planning (achieving pregnancy only),” “For family planning (avoiding pregnancy only),” “For 
family planning (achieving and avoiding pregnancy),” “For family planning (achieving 
pregnancy only) and health monitoring,” “For family planning (avoiding pregnancy only) and 
health monitoring,” “For family planning (achieving and avoiding pregnancy) and health 
monitoring,” and “I would not use FABMs for monitoring my health or for family planning, 
even if I was confident in reliability, it was easy to learn and acceptable to my partner.” 
Additional questions were adapted from previous studies measuring female interest in FABM 
use for family planning (Stanford et al., 1998; Leonard et al., 2006).  Additionally closed-ended 
vs. open ended and multiple choice questions were generated to measure the extent to which 
participants were familiar with FABMs, (e.g., “Please check below ALL Fertility Awareness 
Based Methods (FABMs) that you are at all FAMILIAR with even if you have never used an 
FABM”), prior use of FABMs to monitor reproductive health (e.g., “Please check below 
ALL Fertility Awareness Based Methods (FABMs) that you have EVER used TO MONITOR 
YOUR REPRODUCTIVE/MENSTRUAL CYCLE HEALTH ONLY. ***This does NOT 
include using FABMs for the purposes of trying to achieve or avoid pregnancy.***”), with a 
follow-up open-ended question prompting the participant to elaborate on having used the 




to monitor your reproductive/menstrual cycle health. Please explain what the Calendar Rhythm 
Method is.”).  The remaining questions inquired about prior participant use of FABMs for family 
planning (avoiding or achieving pregnancy), a “select all that apply” option choice was used for 
all questions.  If participants selected prior use of the Calendar Rhythm Method for family 
planning they were not promoted to explain the Calendar Rhythm Method.  Lastly, participants 
were asked to “select all that apply” when identifying other females, they believed might be 
interested in learning more about FABMs for family planning or health monitoring.  Upon 
completion of the survey participants were provided direct links to various FABM teaching 
organizations if they wanted to learn more about a particular method.   
Data Analysis 
Statistical analysis was carried out using the Statistical Package for the Social Sciences 
(SPSS).  Prior to calculating the mean reproductive health knowledge score, one knowledge 
question was eliminated (e.g., “True or False: It is not necessary for a female to ovulate regularly 
in order to be considered healthy as long as she is regularly bleeding.”).  This question was 
removed because of conflicting findings in research that suggest ovulation is not essential for 
health and findings that suggest it is essential for health (Guttmacher Institute, 2011; Vigil et al., 
2017).  Thus, the mean knowledge score was calculated using the remaining six knowledge 
questions.  After this question was eliminated, frequency and percent rates were generated for 1) 
the six reproductive health knowledge questions 2) prior or current use of hormonal birth control 
to treat reproductive health problems and 3) when participants indicated they would consider 
using FABMs.   
Participant responses to the survey question, “When would you consider using a FABM? 




allowed for participants to choose one of the options that included family planning only, health 
monitoring only, or a combination of both. For the purpose of the analyses, these responses were 
recoded into two different variables, one for interest in using FABMs for family planning, and 
the other for interest in using FABMs for health monitoring.  To do this, any answer choice that 
included use for family planning was coded as ‘yes’ for interest in FABMs for family planning. 
Answer choices that indicated no interest in use for family planning, or use only for health 
monitoring, were coded as ‘no’ for interest in FABMs for family planning. Similarly, any answer 
choice that indicated interest in FABMs for health monitoring was recoded to reflect the 
selection of an answer choice with health monitoring as ‘yes’ and the selection of an answer 
choice without health monitoring as ‘no’.   
Due to the distribution of categorical demographic variables, some variables were 
dichotomized for the purpose of analyses. Demographic variables were dichotomized as follows: 
1) race/ethnicity: white & non-white 2) relationship status: committed & non-committed 3) 
highest level of academic achievement: some college and above & no college 4) insurance status: 
insured & no insurance and 5) religiously affiliated and not affiliated.  Given the homogeneous 
makeup of the participant sample, all females, participants’ sex was not included in the analysis.  
In addition, the independent and categorical variable, prior or current use of hormonal birth 
control for reproductive health problems (e.g., “Have you ever used or are currently using a birth 
control pill or other hormonal contraceptive method as a treatment for a reproductive health 
problem, such as irregular cycles, painful periods, bad cramps, heavy periods, other…”) was re-





Research question one. 
Two independent samples t-tests were run to answer the first research question, “Is there 
a difference between the mean knowledge scores of females who are interested or not interested 
in using FABMs for family planning or health monitoring?”  The hypothesis was, there was no 
difference between the mean knowledge scores of females interested or not interested in FABMs 
for family planning or health monitoring.  Mean knowledge scores were calculated for each 
group (interested and not interested) by averaging the number of correct responses to the six 
knowledge questions.  Participant responses were scored as correct or incorrect.  The average 
knowledge score for a participant that answered all six knowledge questions correctly was one.  
The independent variable was the mean knowledge score.  The dependent variables were female 
interest in using FABMs for family planning or health monitoring.  
 Research question two.  
Two binary logistic regression models were used to answer the second research question, 
“Does having been prescribed the hormonal birth control pill for health problems and certain 
demographic characteristics predict female interest in using FABMs for family planning or 
health monitoring?”  The null hypothesis was that no demographic characteristics or prior or 
current use of hormonal birth control for a reproductive health problem would predict female 
interest in using FABMs for family planning or health monitoring.  The research hypothesis was 
that one or more demographic variables would predict female interest in using FABMs for health 
monitoring or family planning.  A second hypothesis was that previous or current use of 
hormonal birth control would positively predict female interest in using FABMs for health 
monitoring but not family planning.  Independent variables included the demographic 




control.  Dependent variables were female interest in using FABMs for family planning or health 
monitoring. 
Results 
Almost 75% (n = 493) of females indicated that they would consider using a FABM for 
health monitoring or family planning, while 25% (n = 172) of participants would not use a 
FABM for health monitoring or family planning (see Appendix A, Table 2).  Of these women, 
58% (n = 386) indicated they would consider using a FABM for family planning, and 42.8% (n = 
285) would use a FABM for health monitoring.  In contrast, 41.9% (n = 279) females would not 
consider using a FABM for family planning, and 57.1% (n = 380) would not consider using a 
FABM for health monitoring. 
Research Question 1.  Frequencies showed that 4.5% of females (n = 30) correctly 
identified short, regular, and long cycle lengths as possible healthy menstrual cycle lengths (see 
Appendix A, Table 3).  The majority of females, 98.1%, correctly identified a healthy number of 
days for a female to be menstruating (n = 652).  When asked, “Can a female become pregnant 
while on her menses?”, 68.5% of participants responded, “Yes,” (n = 456), 19.4% selected, 
“No,” (n = 129), and 12% answered, “I don’t know,” (n = 80).   A fourth of females, 25% (n = 
166), did not correctly identify, “One,” as the correct number of days a female ovulates each 
menstrual cycle.  Of the 665 study participants, 59.5% (n = 396) chose, “True,” when responding 
to the ‘True/False’ statement, “Females are able to get pregnant at ANY time in their menstrual 
cycle.”  Over 75%, (n= 532) of females indicated that females can identify when they are fertile 
by identifying external biological markers.   
Contrary to the hypothesized outcome, there was a significant difference (p<.05) in the 




family planning (M= 0.75, SD= 0.23) or health monitoring (M= 0.73, SD= 0.23) and females 
who were interested in using FABMs for family planning (M= 0.69, SD= 0.23) or health 
monitoring (M= 0.68, SD= 0.23) (see Appendix A, Table 4).  For both outcomes, independent 
samples t-test results suggested those who were not interested in using FABMs had higher mean 
knowledge scores.   
Research Question 2. Two binary logistic regression tests were conducted to predict 
interest in using FABMs for family planning (n = 386) and health monitoring (n=285).  Predictor 
variables included age, annual household income, and the dichotomized demographic variables: 
race (white/non-white), religion (religiously affiliated/not religiously affiliated), 
relationship/marital status (committed/non-committed), education (some college/no college), and 
insurance status (insured/not insured).  Prior or current use of hormonal birth control for 
reproductive health was also added as an independent, categorical, predictor variable that was 
dichotomized for both regression models (see Appendix A, Table 5). 
The Hosmer and Lemeshow test was used to measure how well the data fit the statistical 
models, where an alpha level greater than .05 indicates a good fit (Bertolini, D'Amico, Nardi, 
Tinazzi, & Apolone, 2000). The data fit the two regression models for health monitoring (p= 
0.704) and family planning (p = 0.475).  No demographic variable, nor the use of hormonal birth 
control for health problems, significantly predicted (p < .05) female interest in using FABMs for 
health monitoring or family planning (see Appendix A, Table 6). Although, some variables did 
show a marginal significance (p < .10).  For example, a trend in the data suggests that as 
previous or current use rates of hormonal birth control for reproductive health problems increase, 
interest in using FABMs for health monitoring decreases (OR: 0.876, CI: 0.63-1.20).  In addition, 




0.962-1.00).  Thus, these results conclude a failure to reject the null hypothesis. The pseudo R2, 
Nagelkerke R2, did not suggest a significant relationship between the independent and dependent 
variables, 0.021 (interest in health monitoring) and 0.028 (interest in family planning). 
Discussion 
 The purpose of this study was to explore whether females were interested or not 
interested in using FABMs for family planning and health monitoring in a national sample of 
women of reproductive age. First, differences were examined in the mean reproductive health 
knowledge scores for those participants indicating that they were and were not interested in using 
FABMs.  The results suggest that females with lower mean reproductive health knowledge 
scores were more likely to be interested in using FABMs for health monitoring and for family 
planning.  Differences in knowledge scores for participants who were and were not interested in 
using FABMs for family planning revealed, contrary to the hypothesis, those who were not 
interested in using FABMs for family planning had higher knowledge scores than those who 
were interested.  Again, contrary to the hypothesis, those who were not interested in using 
FABMs for health monitoring had significantly higher mean knowledge scores than those who 
were interested.  Perhaps females with more reproductive health knowledge are less interested in 
using a FABM for family planning or health monitoring because they feel confident in their level 
of fertility awareness and do not believe learning about a specific FABM is necessary. In 
contrast, females with lower mean knowledge scores may be more interested in FABMs for 
family planning and health monitoring because of a desire to learn more and fill the gaps in their 
fertility awareness knowledge.  Therefore, females who are interested in using FABMs for 




receive while learning to use a FABM from a trained educator (Arevalo et al., 2004; Fehring et 
al., 2013; Hilgers & Stanford, 1998; World Health Organization, 1981).   
Previous research examining reproductive knowledge related topics asked different 
questions and used a different scoring system (Kudesia et al., 2017; Lampic et al., 2006; 
Lundsberg et al., 2014; Peterson et al., 2012; Prior et al., 2018; Slap, 2003; Sorensen et al., 2016; 
Stern et al., 2013).  Thus, findings from this study are hard to compare with findings from most 
other research measuring fertility health-related knowledge.  That being said, the response 
frequencies for the individual knowledge questions found in this study corroborate with ACOGs’ 
(2015) claim that females are not aware of what cycle patterns are healthy and unhealthy. 
 Results from this study suggest that current or previous use of hormonal birth control for 
reproductive problems and demographic characteristics are not significant (p<.05) predictors of 
female interest in using FABMs for health monitoring or family planning. Previous research by 
Stanford and colleagues, (1998) did find that age (<30 years old) was a significant predictor of 
female interest in using FABMs to achieve pregnancy (family planning).  A similar trend was 
found in this study suggests that as participant age decreased interest in using FABMs for health 
monitoring (OR: 0.98, CI: 0.96-1.00) and family planning (OR: 0.981, CI: 0.96-1.00) increased 
(see Appendix A, Table 6).  Unlike this study, Leonard and colleagues, (2006) found that 
educational attainment significantly predicted female interest in using FABMs to avoid 
pregnancy (family planning).  In contrast with Stanford and colleagues (1998) and Leonard and 
colleagues (2006), this study explored the previous or current use of hormonal birth control for 
health monitoring and demographic characteristics as predictor variables of female interest.  




of natural family planning (NFP) methods, or a select number of demographic characteristics 
predicted female interest in the use of FABMs for family planning.   
Surprisingly, the use of hormonal birth control did not predict interest in FABMs for 
health monitoring.  FABMs are side-effect free alternatives to hormonal methods currently used 
to diagnose, manage, and treat reproductive health problems (Briden, 2017; Legro et al., 2013).  
In light of the large percentage of females that report discontinuing hormonal birth control due to 
side-effects, it was hypothesized that FABMs would be an interesting alternative for females 
prescribed hormonal methods for health problems. Findings from this study suggest that this may 
not be the case.  In fact, marginally statistically significant (p < .10) trends in the data support the 
opposite.  Given that no demographic variable significantly predicted female interest in the use 
of FABMs for health monitoring or family planning, FABM programs could be applicable and 
may be of interest to a broad range of the population.   
Limitations 
Some limitations deserve to be highlighted.  While the participant sample size (n= 665) 
was drawn from a national participant pool it is not nationally representative.  For example, 73% 
of the participants were White/Caucasian. In addition, the knowledge questions used in this study 
were created or adapted from other research. Therefore, this is not a previously validated 
instrument to measure reproductive health knowledge. Such an instrument does not exist.  Future 
research may attempt to create a reliable measure to assess knowledge.  While such surveys exist 
to measure knowledge about fertility as it pertains to the ability to conceive, that was not the goal 
of this study and therefore such instruments were not applicable.  Furthermore, the survey is 
quite lengthy, a total of 52 questions.  Therefore, participant burnout is also a potential threat to 




Future Research and Implications for Public Health 
 This study contributes to the literature on females’ interest in FABMs for family planning 
and health monitoring in three ways, 1) promoting FABM use in clinical practice 2) suggesting 
female interest in FABMs for health monitoring and 3) the need to improve reproductive and 
fertility health literacy by way of FABM public health programs.  First, results suggest that 
women from a national sample, and of reproductive age, are interested in using FABMs for 
family planning and health monitoring.  This finding is perhaps most descriptive of the interest 
of younger women.  Further research is needed to explore physicians current knowledge about 
these methods as well as exploring their beliefs and attitudes about FABMs and their intentions 
to offer them in the clinical setting.  Depending on those findings, research may need to examine 
how clinicians can improve their medical knowledge about the science and application of 
modern FABMs so that these methods can be offered to patients during family planning and 
reproductive health appointments. Second, this was the first study to assess females' interest in 
using FABMs for health monitoring, and we found that many are, indeed, interested in using 
them for this purpose (42.8%). Studies investigating how to best promote FABM use for health 
monitoring may help current and future FABM professionals more effectively market these 
methods to reproductive age women.  Given that female interest in FABMs does not translate 
into the use of these methods, it may be helpful to explore factors that influence females’ 
intention to use FABMs (Mikolajczyk, Stanford, & Rauchfus, 2003).  Ones’ intention to perform 
a behavior is arguably the best predictor of behavior (Ajzen & Klobas, 2013).  Therefore, future 
research should explore the degree to which females’ attitudes, subjective norms, and perceived 
behavioral control predict their intention to perform FABM related health behaviors (e.g., 




exploring females’ beliefs and knowledge about FABMs and their applications for reproductive 
health may provide insight about why more participants were interested in FABMs for family 
planning over health monitoring.  Third, findings from this study corroborate findings from 
previous research as well as the recommendations from ACOG suggesting that public health 
researchers need to consider how to best improve or develop programming and intervention 
efforts that address reproductive health literacy in the general population (ACOG, 2015; Kudesia 
et al., 2017; Lampic et al., 2006; Lundsberg et al., 2014; Peterson et al., 2012; Prior et al., 2018; 
Slap, 2003; Sorensen et al., 2016; Stern et al., 2013).  An increase in patients’ reproductive 
health literacy is suggested as a way to hasten the identification and treatment of reproductive 
diseases, disorders, and conditions in order to improve long term reproductive health outcomes 
(ACOG, 2015).  Certain FABM educational programs may be effective ways to address the 
knowledge gap and equip females with the necessary skills to monitor their female ‘fifth vital 
sign’.  Further research is needed to explore how such programs should be structured, identify 
the ideal setting for program implementation, and measure the short and long term outcomes 
(knowledge, health, etc.) of these programs.  Further research is needed to explore physicians 
current knowledge about these methods as well as exploring their beliefs and attitudes about 
FABMs and their intentions to offer them in the clinical setting.  Finally, more research is needed 
to examine why females with higher knowledge scores are less interested in using FABMs for 
health monitoring and family planning. 
Conclusion 
Females are interested in using FABMs.  The American College of Obstetricians and 
Gynecologists (ACOG) suggests that females track their reproductive health patterns in order to 




others suggest women do not have a sufficient level of reproductive health knowledge in order to 
monitor their cycle patterns (ACOG, 2015; Kudesia et al., 2017; Lampic et al., 2006; Lundsberg 
et al., 2014).  Further research is needed to explore whether females have the skills and intention 
to perform health behaviors associated with monitoring their reproductive cycle patterns.  In 
addition, FABMs should be offered to patients during family planning appointments. Broader 
dissemination of FABM information and greater efforts to promote their use should be 
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Summary of demographic variables (n=665) 
 
Demographic Variables Mean SD 
Age 31.11 8.44 
 Frequency Percent 
Religious Affiliation   
   Christian (Protestant) 143 21.5 
   Christian (Catholic) 159 23.9 
   Christian (Mormon/LDS) 14 2.1 
   Christian-Orthodox 24 3.6 
   Judaism 9 1.4 
   Islam 6 .9 
   Buddhism 6 .9 
   Hinduism 8 1.2 
   Atheist 32 4.8 
   Agnostic 50 7.5 
   Spiritual but not religious 68 10.2 
   Other 68 10.2 
   None 78  11.7 
Relationship/Marital Status   
   Married 262 39.4 
   Engaged 39 5.9 
   Single 180 27.1 
   Casually Dating 37 5.6 
   Living with a partner 119 17.9 
   Divorced 24 3.6 
   Widowed 4 .6 
Race   
   White/Caucasian 487 73.2 
   Black/African American 89 13.4 
   Hispanic 41 6.2 
  Native American 5 .8 
  Asian 29 4.4 
  Pacific Islander 1 .2 




Table 1 (Cont.) 
 
Summary of demographic variables (n=665) 
  
Demographic Variables Mean SD 
Age 31.11 8.44 
 Frequency Percent 
Education   
   Less than a high school diploma 14 2.1 
   Some high school/vocational school 23 3.5 
   Vocational/Technical School 16 2.4 
   High school graduate or G.E.D 146 22.0 
   Some college 188 28.3 
   Associates degree 78 11.7 
   Bachelors degree 155 23.3 
   Master’s level graduate 33 5.0 
   Doctorate level graduate 3 .5 
   Professional degree 4 .6 
   MD 1 .2 
   JD 1 .2 
   Other 3 .5 
Insurance Status   
   Yes 567 85.3 
   No 88 13.2 
   I don’t know 10 1.5 
Annual Household Income   
   Less than $15,000 113 17.0 
   $15,000-$30,000 123 18.5 
   $30,000-$45,000 119 17.9 
   $45,000-$60,000 110 16.5 
   $60,000-$75,000 71 10.7 
















For health monitoring 107 16.0 
For family planning (achieving pregnancy) 97 14.5 
For family planning (avoiding pregnancy) 49 7.3 
For family planning  
(achieving and avoiding pregnancy) 
62 9.3 
For family planning (achieving pregnancy only) 
and health monitoring 
56 8.4 
For family planning (avoiding pregnancy only) 
and health monitoring 
32 4.8 
For family planning (achieving and avoiding 
pregnancy) and health monitoring 
90 13.5 
I would not use a FABM for monitoring my 
health or for family planning 
172 25.8 








Summary of responses to reproductive health knowledge questions 
 
 
   
Knowledge Questions Answer Choices Frequency Percent 
What is considered a  
healthy menstrual cycle  
length? 
(Select all that apply) 
   
 Short Cycles (21-25 days) 157 23.6 
 Regular length cycles (26-
35 days) 
472 70.9 
 Long cycles (36-48 days) 75 11.2 
 Cycle Lengths of ONLY 
28 days 
156 23.4 
 Other 33 4.9 
 Short Cycles (21-25 
days), Regular length 
cycles (26-35 days), Long 
cycles (36-48 days)* 
30 4.5 
How many days is  
considered a healthy  
length of menses 
(bleeding)? 
   
 1 day 3 .5 
 2 days* 38 5.7 
 3 days* 104  15.6 
 4 days* 279 42.0 
 5 days* 3 .5 
 7 days* 60 9.0 
 8 days* 168 25.3 
 9 days 2 .3 
 10 days 3 .5 
 11 days 2 .3 
 12 days 0 0 





Table 3 (Cont.) 
 
Summary of responses to reproductive health knowledge questions 
 
   
Knowledge Questions Answer Choices Frequency Percent 
Can a female become  
pregnant while on her  
menses? 
   
 Yes* 456 68.5 
 No 129 19.4 
 I don’t know 80 12.0 
How many days in each 
Menstrual cycle does a  
female ovulate? 
   
 One* 166 25.0 
 Two 54 8.1 
 Three 111 16.7 
 A woman can ovulate 
once a day for more than 
three days each cycle 
148 22.3 
 I don’t know 186 28 
True or False: A female is 
able to get pregnant at ANY 
time in her menstrual cycle? 
   
 True 396 59.5 
 False* 269 40.5 
True or False: Females are 
able to identify when they 
are fertile by monitoring 
external physical signs 
such as basal body  
temperature, cervical fluid 
discharge, or measuring 
urinary hormone levels.  
   
 True* 532 80 
 False 33 5 
 I don’t know 100 15 
Notes: *Correct answer 
**Responses were scored "correct" only if the correct answer was selected. All other options 






Results of t-test for females interested and not interested in using FABMs for health monitoring 
and family planning 
 
      
  Interested  Not Interested   
  n M SD  n M SD t p 
Family planning  Mean 
Knowledge 
Score  
386 .69 .20  279 .75 .23 -3.48 .00* 
Health monitoring Mean 
Knowledge 
Score  
285 .68 .20  380 .73 .23 -2.77 .00* 
 
Note: * p < .05. 
 
Table 5  
Number of participants who have used or are currently using a birth control pill or other 
hormonal contraceptive method as a treatment for a reproductive health problem, such as 
irregular cycles, painful periods, bad cramps, heavy periods, other 
 
Answer Choice 
 Frequency Percent 
Yes 350 52.6 
No  315 47.4 









Summary of Binary Regression Analysis for Variables Predicting Females’ Interest in Using 
FABMs for Health Monitoring or Family Planning  
 
 Interest in FABMs (HM) Interest in FABMs (FP) 
Variables    95% C.I. for β    95% C.I. for β 
     B SE B β Lower Upper B SE B β Lower   Upper 
Age -.015 .010 .985 .966 1.005 -0.19 .010 .981 .962 1.001 





.242 .186 1.27 .885 1.833 .302 .184 1.35 .943 1.939 
Insurance Status  
(insured/not insured) 
 
.350 .246 1.42 .877 2.298 .194 .238 1.21 .761 1.93 

















































           
Race  
(white/not white) 
.248 .185 1.28 .892 1.841 -.014 .185 .006 .686 1.417 
 
Use of Pill  
(used the pill/never 





















           
Constant Nagelkerke 
R Square 
   
.02 
     
.028 
  
N   665     665   
Note: *p  <  .05.   
HM: Interest in FABMs for health monitoring 






FABM Interest Survey 
 
 
Start of Block: Demographic Questions 
 
Q107 INFORMED CONSENT STATEMENT 
 Female Interest in Fertility Awareness Based Methods (FABMs): For Health Monitoring 
and Family Planning 
 IRB# 
   Amylynn Smith, BS, CFCP University of Arkansas 
 Heather D. Blunt-Vinti, MPH, PhD  
 University of Arkansas 
   
 The Department of Health, Human Performance, and Recreation at the University of Arkansas 
supports the practice of protection for human subjects participating in research. The following 
information is provided for you to decide whether you wish to participate in the present study. 
You should be aware that participation is completely voluntary and that even if you agree to 
participate, you are free to withdraw at any time without penalty. Your relationship with the 
investigators will not be affected in any way if you refuse to participate. 
   
 We are conducting this study to better understand female knowledge of and interest in fertility 
awareness based methods (FABMs) for reproductive health monitoring and family planning. 
This will entail your completion of an anonymous online questionnaire. The questionnaire is 
expected to take less than 25 minutes to complete. If you participate in this study you will be 
one of approximately 3,000 individuals participating in the study. You must be at least 18 years 
old to participate. 
   
 This survey includes questions about your person knowledge about basic fertility cycle health, 
your interest in FABMs for health monitoring and family planning, as well as your satisfaction 
with prior family planning methods. If you do not wish to answer a specific question, you may 
leave it blank. If at any time you do not wish to continue with this survey, you can exit the study 
website. 
   
 Although participation may not benefit you directly, we believe that the information obtained 
from this study will help us gain a better understanding of what options females prefer for 
reproductive health monitoring and family planning options, which may help public health and 
education professionals to better design educational programs and research projects in these 
areas. In addition, this information may help to encourage the medical community to broaden 
the scope of family planning options they provide to patients and how they treat reproductive 
health problems. You may also receive compensation from Qualtrics® for your participation. 




 All efforts will be made to keep your personal information confidential and the survey will not 
collect any identifying information about you (such as your name, birthdate, etc.). We cannot 
guarantee absolute confidentiality. Any personal information you provide may be disclosed if 
required by law. Your identity will be held in confidence in reports in which the study may be 
published and databases in which results may be stored. The researchers have no connection 
to any products mentioned in the survey, although aggregate results may be shared with the 
company. 
    
 Your participation is solicited, although strictly voluntary. If you would like additional information 
concerning this study before or after it is completed, please feel free to contact us by phone or 
e-mail. At the conclusion of the study, you will have the right to request feedback about the 
results. 
   
 Starting the survey indicates your willingness to participate in this project and that you are at 
least the age of 18. If you have any additional questions about your rights as a research 
participant, you may contact either of the following: 
   
 The University of Arkansas Research Compliance: 
 Phone: 479-575-2208 
 Email: irb@uark.edu 
 Mail: 
 Ro Windwalker, CIP 
 Institutional Review Board Coordinator 
 Research Compliance 
 University of Arkansas 
 109 MLKG Building 
 Fayetteville, AR  72701-1201 
   
 Or 
  
 Amylynn Smith, BS, CFCP Principal Investigator 
 Department of Health, Human Performance and Recreation 
 University of Arkansas 
 308-T HPER Building 
 Fayetteville, AR, 72701 
 (813) 352-4404 
 as115@uark.edu 
  
 Heather D. Blunt-Vinti, PhD. Principal Investigator 
 Department of Health, Human Performance and Recreation 
 University of Arkansas 
 308-T HPER Building 
 Fayetteville, AR, 72701 





    Note: if possible we strongly encourage that you complete the survey on a device other than 
a mobile phone. 
  




Q104 The purpose of this study, Female Interest in Fertility Awareness Based Methods 
(FABMs): For Health Monitoring and Family Planning, is to inquire about your current level of 
knowledge in regards to reproductive health and fertility cycle patterns. FABMs  are modern 
methods of family planning that can be used by females and their partners to monitor their 
reproductive health and as a means of achieving or preventing pregnancy.   
    
In addition, we want to know what methods of family planning you have used or are currently 
using and if at anytime you discontinued the use of a method and for what reason. We are also 
curious if you currently use any of the fertility or period tracking apps available and if so for what 
purpose you use them. Lastly, we hope to briefly introduce you to FABMs (if you aren't currently 
familiar with them), to learn about your current level of familiarity with FABMs, and your level of 
interest in learning to use these methods for various purposes.    
    
This information will enable us to share with the public health and medical community the level 
of interest you and women across the nation have in using, or at least learning more about 
FABMs.   
    




Q39 What is your age 
▼ 17 and under ... 56 and older 
 
Skip To: End of Survey If What is your age = 17 and under 
Skip To: End of Survey If What is your age = 56 and older 
 
 
Q47 In what state of the United States do you currently live? 







Q40 What ethnicity/race do you most identify with? 




Q41 What is your sex? 
o Male  
o Female  
o Other (please specify): ________________________________________________ 
 
Skip To: End of Survey If What is your sex? = Male 
Skip To: End of Survey If What is your sex?(Other (please specify):) Is Not Empty 
 
 
Q48 What is your current marital/relationship status? 




Q44 What is your religion (if any)? 




Q43 What is the highest level of education you have completed? 







Q45 Which of the following categories is closest to the total income of your household per year? 




Q46 Do you currently have health insurance? 
o Yes  
o No  




Q52 How many times have you been pregnant? 




Q54 How many pregnancies have you had that resulted in the birth of a living child? (total 
number of children born alive) 




Q2.3 Please check below any of the conditions or surgeries that you have had (check all that 
apply): 
▢ Menopause (change of life)  
▢ Hysterectomy (uterus removed)  
 
Skip To: End of Survey If Please check below any of the conditions or surgeries that you have had (check 




Skip To: End of Survey If Please check below any of the conditions or surgeries that you have had (check 
all that apply): = Hysterectomy (uterus removed) 
End of Block: Demographic Questions 
 
Start of Block: Fertility Health Questions 
 
Q53  
The following questions are for the purpose of understanding your current knowledge about the 
female menstrual cycle, and your experience with medical providers treating menstrual cycle 
problems.   
  For the purpose of this survey we define menstrual cycle, menses, and ovulation as:   
 menstrual cycle:  All of the days from the start of one period until the day before your 
next period  menses: The days of your cycle when you are bleeding   ovulation: When the 




Q1.2 What is considered a healthy menstrual cycle length? (Select all that apply) 
▢ Short Cycles (21-25 days)  
▢ Regular Length Cycles (26-35 days)  
▢ Long Cycles (36-48 days)  
▢ Cycle lengths of ONLY 28 days  




Q60 How many days is considered a healthy length of menses (bleeding)? 







Q91 Can a female become pregnant while on her menses? 
o Yes  
o No  




Q54 How many DAYS in each menstrual cycle does a female ovulate? 
o One  
o Two  
o Three  
o A woman can ovulate once a day for more than three days each cycle  




Q51 True or False: It is NOT necessary for a female to ovulate regularly (approximately once a 
month) in order to be considered healthy as long as she is regularly bleeding. 
o True  
o False  




Q59 True or False: A female is able to get pregnant at ANY time in her menstrual cycle? 
o True  







Q50 True or False:    
Females are able to identify when they are fertile by monitoring external physical signs such as: 
basal body temperature, cervical fluid discharge, or measuring urinary hormone levels.  
   
o True  
o False  




Q70 This question is to make sure you are truly reading and answering the questions. If you are 
reading and answering questions please choose, "I am reading and answering questions," as 
your answer choice. 
o I am not really reading  
o I don't care  
o I am reading and answering questions  
 
Skip To: End of Survey If This question is to make sure you are truly reading and answering the 
questions. If you are readi... = I am not really reading 
Skip To: End of Survey If This question is to make sure you are truly reading and answering the 






Q92 Where did you learn about what a healthy menstrual cycle is? Select all that apply. 
▢ Father  
▢ Mother  
▢ Sibiling  
▢ Other family member  
▢ A friend  
▢ An FABM educator  
▢ Sex education Class (school-based program)  
▢ General Health/Science Class  
▢ A partner  
▢ A medical website  
▢ Social media  
▢ Women's health care professional  
▢ Primary care physician  
▢ Product labels  




▢ Community health class  
▢ Planned Parenthood  




Q111 Have you ever used or are you currently using a birth control pill or other hormonal 
contraceptive method as a treatment for a reproductive health problem such as:   
 Irregular cycles  Painful periods  Bad cramps  Heavy periods  Other  
o Yes  
o No  
 
 
Display This Question: 
If Have you ever used or are you currently using a birth control pill or other hormonal contraceptiv... = 
Yes 
 
Q112 If you have used, or are currently using, a birth control pill or other hormonal contraceptive 
as a treatment for a reproductive health problem, who prescribed the treatment? 
o Medical Professional  
o Self-Prescribed  
o Parent/Family Member  






Display This Question: 
If If you have used, or are currently using, a birth control pill or other hormonal contraceptive as... = 
Medical Professional 
Or If you have used, or are currently using, a birth control pill or other hormonal contraceptive as... = 
Self-Prescribed 
Or If you have used, or are currently using, a birth control pill or other hormonal contraceptive as... = 
Parent/Family Member 
Or If you have used, or are currently using, a birth control pill or other hormonal contraceptive as... = 
Other 
 
Q115 Select the reason you FIRST started using the birth control pill or other hormonal 
contraceptives to treat a reproductive health problem? 
 
 
Choose ALL that apply. 
▢ Irregular Cycles  
▢ Too long in-between periods  
▢ Painful Periods  
▢ Heavy Periods  
▢ Severe Cramping  






Display This Question: 
If Select the reason you FIRST started using the birth control pill or other hormonal contraceptives... 
= Irregular Cycles 
Or Select the reason you FIRST started using the birth control pill or other hormonal contraceptives... 
= Too long in-between periods 
Or Select the reason you FIRST started using the birth control pill or other hormonal contraceptives... 
= Painful Periods 
Or Select the reason you FIRST started using the birth control pill or other hormonal contraceptives... 
= Heavy Periods 
Or Select the reason you FIRST started using the birth control pill or other hormonal contraceptives... 
= Severe Cramping 




At what age did you FIRST start taking the birth control pill or other hormonal contraceptives as 
a treatment for your reproductive health problem(s)? 




Q89 The behaviors listed below are ways you can monitor your menstrual cycle health, and 




prevent pregnancy without the use of hormonal supplements, devices, or other methods of 




 I am NOT willing I might be willing 
if I knew more 
I am willing I am already 
doing this 
Keeping track of 
my period 
lengths  





o  o  o  o  
Wiping with toilet 
tissue before 
and after EVERY 
bathroom visit to 




o  o  o  o  
Wiping with toilet 
tissue before 
and after EVERY 
bathroom visit 
looking for 
cervical fluid on 
a tissue  
o  o  o  o  
Wiping with toilet 




testing (trying to 
stretch) cervical 
fluid found on 
your tissue  
o  o  o  o  
Peeing on a stick 
every morning 
and inserting it 
into a monitor 
that tells you 
how likely you 
are to get 
pregnant that 
day if you have 
sex  







saw during the 
day in a chart or 
on an app before 
going to bed 
each night  





Q76 Please check below ALL statements that apply to you. 
▢ I have had my tubes tied (a surgical tubal ligation to prevent pregnancy)  
▢ I have had both of my ovaries removed (not just one)  
▢ I have had a surgery that has made me unable to get pregnant for the rest of my life  
▢ I have a condition that makes me unable to get pregnant for the rest of my life.  
▢ None of the above apply to me  
 
Skip To: End of Survey If Please check below ALL statements that apply to you. = I have had both of my 
ovaries removed (not just one) 
Skip To: End of Survey If Please check below ALL statements that apply to you. = I have had a surgery 
that has made me unable to get pregnant for the rest of my life 
Skip To: End of Survey If Please check below ALL statements that apply to you. = I have a condition that 
makes me unable to get pregnant for the rest of my life. 
Skip To: End of Survey If Please check below ALL statements that apply to you. = I have had my tubes 






Q38 With whom do you intend to or with whom do you engage in sexual activity? 
o Men only  
o Women only  
o Both men and women  
o I do not intend to EVER engage in sexual activity  
 
Skip To: End of Survey If With whom do you intend to or with whom do you engage in sexual activity? = 
Women only 
Skip To: End of Survey If With whom do you intend to or with whom do you engage in sexual activity? = I 
do not intend to EVER engage in sexual activity 
End of Block: Fertility Health Questions 
 
Start of Block: Fertility Monitoring Question 
 
Q105  
The remaining questions will ask you about the following: 
     
1.  What methods of family planning you have used or are currently using 
 2. If at anytime you discontinued the use of a method and for what reason 
 3. Are you currently using any of the fertility or period tracking apps available and if so for what 
purpose you use them. 
4. You will be briefly introduced to fertility awareness based methods (FABMs), asked about 
your current level of familiarity with FABMs, and your level of interest in learning to use these 
methods for various purposes.    
    
 For the purpose of this survey we define menstrual cycle, menses, and ovulation as:   
   menstrual cycle:  as all of the days from the start of one period until the day before your 
next period  menses: the days of your cycle when you are bleeding   ovulation: when the 







Q67 What characteristics are important to you when considering a method to use for family 
planning? (check ALL that apply) 
▢ Reliability (e.g., effectiveness)  
▢ Ease of use  
▢ Acceptability of method to a partner  
▢ Potential side effects  
▢ Cost  







Q1.13 Which method(s) of family planning do you currently use?  Check all that apply. 
▢ Condom  
▢ Withdrawl ("pulling out")  
▢ Birth control pill  
▢ Birth control patch  
▢ Vaginal ring (e.g., NuvaRing)  
▢ The shot (Depo Provera)  
▢ Spermicide foam/jelly/cream/film  
▢ Hormonal IUD (e.g., Mirena, Skyla)  
▢ Non-hormonal IUD (e.g., Paragard)  
▢ Hormonal implant (e.g., Implanon, Nexplanon)  
▢ Diaphragm  
▢ Female tubal sterilization (e.g., tubes tied)  
▢ In Vitro Fertilization (IVF)  
▢ Emergency contraception (e.g., "Plan B")  




▢ Billings Ovulation Method (cervical mucus method)  
▢ Creighton Model Method (cervical mucus method)  
▢ Sympto-Thermal Method  
▢ Sympto-Hormonal Method  
▢ Lacational Amenhorea Method  
▢ Standard Days Method  
▢ Two Day Method  
▢ Other (please specify): ________________________________________________ 
▢ I do not currently use a method of family planning  







Q1.14 Which of the following have you ever used but discontinued using? Please indicate all 
that apply, and provide a reason for discontinuation for each method that you have previously 




 How long did you use this 
method? 
Reason for discontinuation 
Condom    
Withdrawl ("pulling out"); 
reason for discontinuation:  
  
Birth control pill; reason for 
discontinuation:  
  
Birth control patch; reason for 
discontinuation:  
  
Vaginal ring (e.g., NuvaRing); 
reason for discontinuation:  
  
The shot (Depo Provera); 




for discontinuation:  
  
Hormonal IUD (e.g., Mirena, 
Skyla); reason for 
discontinuation:  
  
Non-hormonal IUD (e.g., 
Paragard); reason for 
discontinuation:  
  
Hormonal implant (e.g., 
Implanon, Nexplanon); reason 
for discontinuation:  
  




(e.g., "Plan B"); reason for 
discontinuation:  
  
Female tubal sterilization 
(e.g., tubes tied)  
  
Male sterilization (e.g., 
vasectomy)  
  
Calendar Rhythm    
Billings Ovulation Method 
(cervical mucus method)  
 
Creighton Model (cervical 
mucus method)  
  










Standard Days Method    
Two Day Method    
None of these methods    





Q97 Do you use a period tracking OR fertility tracking app? 
o Yes  
o No  
 
Skip To: Q100 If Do you use a period tracking OR fertility tracking app? = No 
 
Display This Question: 
If Do you use a period tracking OR fertility tracking app? = Yes 
 








Display This Question: 





Q99 What is your purpose(s) for using a period tracking or fertility tracking app? Check all that 
apply. 
▢ To prevent pregnancy  
▢ To achieve a pregnancy  
▢ To monitor timing of menses  
▢ To monitor cycle health  
▢ To predict the start of my menses (my period)  
▢ Other ________________________________________________ 
 
 
Display This Question: 
If What is your purpose(s) for using a period tracking or fertility tracking app? Check all that apply. = 
To prevent pregnancy 
Or What is your purpose(s) for using a period tracking or fertility tracking app? Check all that apply. = 
To achieve a pregnancy 
Or What is your purpose(s) for using a period tracking or fertility tracking app? Check all that apply. = 
To monitor timing of menses 
Or What is your purpose(s) for using a period tracking or fertility tracking app? Check all that apply. = 
To monitor cycle health 
Or What is your purpose(s) for using a period tracking or fertility tracking app? Check all that apply. = 
To predict the start of my menses (my period) 






Q48 What is your commitment to the period tracking or fertility tracking app? 
o Downloaded app(s) but do not use the regularly  
o Downloaded app(s) and use it regularly for period tracking  
o Downloaded app(s) and use it regularly for fertility tracking  
o Downloaded app(s) and use it regularly for period and fertility tracking  




Q100 Have you ever made a decision about whether to have intercourse (or whether to use a 
condom or withdrawal method), based on whether you thought it was a fertile day or not? 
o Yes  
o No  
o I do not recall  
 
Skip To: Q51 If Have you ever made a decision about whether to have intercourse (or whether to use a 
condom or wi... = No 
Skip To: Q51 If Have you ever made a decision about whether to have intercourse (or whether to use a 
condom or wi... = I do not recall 
 
Display This Question: 
If Have you ever made a decision about whether to have intercourse (or whether to use a condom or 
wi... = Yes 
 
Q101 If yes, was that decision about whether to have intercourse (or whether to use a condom 
or withdrawal method) based on information you gained from your fertility tracking or period 
tracking app(s)? 
o Yes  




Q51 Natural or fertility awareness based methods (FABMs) are modern methods of family 




their partners to achieve or prevent pregnancy.    FABMs are based on the external 
observation and tracking of various biological markers (for example: cervical fluid discharge, 
basal body temperature, monitoring of urinary hormones).   FABMs can be used by women with 
REGULAR and IRREGULAR cycle patterns  FABMs use NO chemicals, NO internal devices, 
and have ZERO medical side effects.     
    
When couples use modern FABMs correctly, they are 95-99.5% effective at preventing 
pregnancy. With typical use, which includes women or couples that may make mistakes in using 
the methods, the effectiveness rates for avoiding pregnancy is 78-98%.   
    
In addition, in 2015 the American College of Obstetricians and Gynecologists, in collaboration 
with the American Academy of Pediatrics, encourage ALL adolescent females to monitor their 
menstrual cycles (timing of menses, patterns of cycles, and associated symptoms- pain, 







Q66 Please check below ALL Fertility Awareness Based Methods (FABMs) that you are at all 
FAMILIAR with even if you have never used an FABM. 
▢ Calendar rhythm  
▢ Creighton Model Method (Cervical Fluid)  
▢ Billings Ovulation Method (Cervical Fluid)  
▢ Sympto-thermal  
▢ Sympto-Hormonal (Marquette Method)  
▢ Lacational Amenhorea Method  
▢ Standard Days Method  
▢ Two Day Method  
▢ Family of the Americas (Cervical Fluid Method)  
▢ FEMM (Fertility Education and Medical Management)  
▢ Justisse Method  
▢ Ecological Breastfeeding  
▢ Taking Charge of Your Fertility  
▢ I have never heard of fertility awareness based methods (FABMs)  







Q1.12 Please check below ALL Fertility Awareness Based Methods (FABMs) that you have 




  ***This does NOT include using FABMs for the purposes of trying to achieve or avoid 
pregnancy.***  
▢ Calendar rhythm  
▢ Creighton Model Method (Cervical Fluid Method)  
▢ Billings Ovulation Method (Cervical Fluid Method)  
▢ Sympto-thermal  
▢ Sympto-Hormonal (Marquette Method)  
▢ Lacational Amenhorea Method  
▢ Standard Days Method  
▢ Two Day Method  
▢ Family of the Americas (Cervical Fluid Method)  
▢ FEMM (Fertility Education and Medical Management)  
▢ Justisse Method  
▢ Ecological Breastfeeding  
▢ Taking Charge of Your Fertility  
▢ I have never used an FABM to monitor or treat my reproductive health  






Display This Question: 
If Please check below ALL Fertility Awareness Based Methods (FABMs) that you have EVER 
used   TO MON... = Calendar rhythm 
 
 
Q110 You marked that you have used the Calendar Rhythm Method to monitor your 
reproductive/menstrual cycle health. 
 
 









Q2.14 When would you consider using an FABM? 
o For monitoring my health  
o For family planning (achieving pregnancy only)  
o For family planning (avoiding pregnancy only)  
o For family planning (achieving and avoiding pregnancy)  
o For family planning (achieving pregnancy only) and health monitoring  
o For family planning (avoiding pregnancy only) and health monitoring  
o For family planning (achieving and avoiding pregnancy) and health monitoring  
o I would not use FABM for monitoring my health or for family planning, even if I was confident 







Q71 This question is to make sure you are truly reading and answering the questions. If you are 
reading and answering questions please choose, "I am reading and answering questions," as 
your answer choice. 
o I am not really reading  
o I don't care  
o I am reading and answering questions  
 
Skip To: End of Survey If This question is to make sure you are truly reading and answering the 
questions. If you are readi... = I am not really reading 
Skip To: End of Survey If This question is to make sure you are truly reading and answering the 




Q2.12 Please check below ALL fertility awareness based methods (FABMs) that you and your 
partner have EVER used TO TRY TO PREVENT PREGNANCY. 
▢ Calendar rhythm
▢ Creighton Model Method (Cervical Fluid Method)
▢ Billings Ovulation Method (Cervical Fluid Method)
▢ Sympto-thermal
▢ Sympto-Hormonal (Marquette Fertility Monitor)
▢ Lacational Amenhorea Method
▢ Standard Days Method
▢ Two Day Method
▢ Family of the Americas (Cervical Fluid Method)
▢ FEMM (Fertility Education and Medical Management)
▢ Justisse Method
▢ Ecological breastfeeding
▢ Taking Charge of Your Fertility
▢ I have never used an FABM to prevent a pregnancy
▢ Other please specify): ________________________________________________
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Q102 Please check below ALL fertility awareness based methods (FABMs) that you and your 
partner have EVER used TO TRY TO GET PREGNANT. 
▢ Calendar rhythm
▢ Creighton Model Method (Cervical Fluid Method)
▢ Billings Ovulation Method (Cervical Fluid Method)
▢ Sympto-thermal
▢ Sympto-Hormonal (Marquette Fertility Monitor)
▢ Lacational Amenhorea Method
▢ Standard Days Method
▢ Two Day Method
▢ Family of the Americas (Cervical Fluid Method)
▢ FEMM (Fertility Education and Medical Management
▢ Justisse Method
▢ Ecological breastfeeding
▢ Taking Charge of Your Fertility
▢ I have never used an FABM to achieve a pregnancy
▢ Other ________________________________________________
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Q2.17 Please mark other females that you think might be interested in learning more about 




▢ Other family member
▢ Friend
▢ Other
▢ I do not think females are interested in learning or using FABMs
87 
Q103 Please mark other females that you think might be interested in learning more about 




▢ Other family member
▢ Friend
▢ Other
▢ I do not think females are interested in learning or using FABMs
Q55 You can find more information about fertility awareness based methods (FABMs) by 
visiting the following websites:  
 Fertility Awareness Based Methods (FABMs): 
 Marquette Method (Sympto-hormonal) 
 Lactational Amenorrhea Method 
 Standard Days Method 
 Two-Day Method 
 Sympto-thermal Method** 
 Creighton Model Method 
 Billings Ovulation Method 
 Justisse Method 
 ***There are multiple methods that teach using the Sympto-thermal approach. This is linked to 
one organization of educators. Below in 'Other Resources' you will find another, FEMM Health. 
On the FACTS page you can find even more resources. 
 Other Resoucres: 
88 
 FEMM Health 
 Fertility Appreciation Collaborative to Teach the Science (FACTS) 
End of Block: Fertility Monitoring Question 
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Appendix C 
